Remarks: Bosutinib is a dual kinase inhibitor. With imatinib, bosutinib both Abl and inhibition of their own SRC kinase, thereby inhibiting cell growth and apoptosis (cell death)
None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer.